No Detail Found!

Association between Interleukin-10 promoter polymorphism with type 2 Diabetes mellitus

Author(s)
Hafiz Umair Hassan Institute of Molecular Biology and Biotechnology, University of Lahore, Pakistan.
Rana Haider Ali Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan.
Hafiz Muhammad Usman Siddiq Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan.
Fahad Ahmed Department of Veterinary Medicine, University of Sassari, Sardinia, Italy.
Hafiz Hanan Taj Institute of Molecular Biology and Biotechnology, University of Lahore, Pakistan.
Muhammad Farhan Rashid Institute of Molecular Biology and Biotechnology, University of Lahore, Pakistan.
Sami Ullah Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan.
Abstract
Type 2 diabetes mellitus is a multifactorial illness triggered by a complicated interplay of various genetic variants with various environmental variables. The quantity of replicated common genetic variants associated with type 2 diabetes mellitus has increased rapidly with the recent genome-wide association (GWA) research. Major health issue in the public are type 2 diabetes mellitus (T2DM) is common throughout the world. Diabetes mellitus incidence is growing and is anticipated to affect 300 million individuals by 2025. Diabetes has been suggested to alter patterns of cytokine expression as an immune-dependent illness. Insulin resistance (IR) is a disease that results in less than anticipated biological impact of a specified insulin concentration. Insulin resistance and insulin secretion decreased are both defined pathophysiology of T2DM. One of the most alarming health issues of the 21st century is the spread of diabetes around the globe. Our goal in this study was to identify the role of IL-10 polymorphism in T2DM patients. The average age of 60 median patients with type 2 diabetes mellitus (31 males and 29 females) ±SD (45.91667 ±16.08799), fasting blood sugar (FBS) is ±SD (184.25 ±57.76387), hypertension (35 positive/25 negative) and 60 non-diabetic controls (32 males and 28 females) is ± SD (47.31667 ±15.13722). The group (T2DM patients and their control) had not a substantial distinction (P=0.33) and in each group (CC, TT, CT) there was a comparison between IL-10 gene polymorphism. T2DM patients and healthy individuals are not associated with the polymorphism of the gene IL-10 (SNP rs 3021097 (C/T).
Publication Details
Page(s) 28-39
Published Journal: Abasyn Journal of Life Sciences, Volume: 4, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Insulin, Polymorphism, Interleukin-10, Diabetes Mellitis Type 2, Genotype frequencies
References
Guillausseau PJ,Meas T,Virally M,Laloi-Michelin M,Medeau V,Kevorkian JP .2008 .Abnormalitie s in insulin secretion in type 2 diabetes mellitus. Diabetes Metab, 34 : 8-43.
Arababadi MK,Naghavi N,Hassanshahi G,Mahmoodi M .2009 .Is CCR5-Delta32 mutation associated with diabetic nephropathy in type 2 diabetes?. Ann Saudi Med, 29 : 413.
Afshin A,Forouzanfar MH,Reitsma MB,Sur P,Estep K,Lee A .2017 .Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med, 377(1) : 13-27.
De-Fronzo RA .1997 .Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Review, 5 : 177-269.
Cuschieri Sarah,Issue 4,July-August 2019 .2020 .The genetic side of type 2 diabetes - A review. Diabetes Metab Syndr, 13 : 2503-2506.
Omoniyi Oguntibeju Oluwafemi .2019 .Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol, 11(3) : 45-63.
Wilson PW,Meigs JB,RB D'Agostino JB .2007 .Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. ArchIntern Med, 167 : 74-1068.
Lee MS,Sarvetnick N .1996 .IL-10 is necessary and sufficient f or autoimmune diabetes in conjunction with NOD MHC homozygosityJ Exp Med. , 183 : 8-2663.
Lee MS .1994 .Pancreatic islet production of murine interleukin-10does not inhibit immune-mediated tissue destruction. J Clin Invest, 93 : 8-1332.
Eskdale J .1998 .Interleukin 10 secretion in relation to human IL-10 locus haplotypes. ProcNatlAcadSciU S A, 95 : 70-9465.
Turner DM,DM Williams D,Sankaran M Lazarus,Sinnott and IV Hutchinson PJ .1997 .An investigation of polymorphism in the interleukin-10gene promoter. Eur J Immunogenet, 24 : 1-8.
Sampaio .2003 .Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics, 54 : 9-896.
Urcelay E,JL Santiago E,de la Calle A,Martinez A,Figueredo M,Fernandez-Arquero and EG de la Concha M .2004 .Interleukin-10 polymorphisms in Spanish type 1 diabetes patients. Genes Immun, 5 : 9-306.
Pickup JC .2004 .Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes, Care27 : 23-813.
Margarida Saraiva,Anne O'Garra Saraiva .2019 .Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. J Exp Med, 217(1) : e20190418.
Chagas BS .2013 .An interleukin-10gene polymorphism associated with the development of cervical lesions in women infected with human papillomavirus and using oral contraceptives. Infect Genet Evol, 19 : 32-37.
Helminen M,Lahdenpohja and M Hurme N .1999 .Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis, 180 : 9-496.
Brookes AJ .1999 .The essence of SNPs. , 234(2) : 177-186.
Yahaya ,Salisu Titilola F,Number 1 .2020 .A Review of Type 2 Diabetes Mellitus Predisposing Genes. Curr.Diabetes Rev, 16(10) : 52-61.
Z-R Zeng ,P-J Hu S Hu,R-P Pang S Hu,M-H Chen M,Ng J J Y Sung .2003 .Association of interleukin 1B ge ne polymorphism and gastric cancers in high and low prevalence regions in China. Gut, 52 : 1684-1689.
Sambrook J,DW Russel J .2001 .Molecular cloning: a laboratory manual. 3rd Edn, : .
Chang YH .2005 .Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Human immunology, 66(12) : 1258-1263.
Ezzidi I,Mtiraoui and M Kacem N .2009 .G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. ClinEndocrinol, 70 : 401-407.
Zhang PA,Li and XS Yang Y .2006 .Associated study on interleukin 10 gene promoter polymorphisms related to hepatitis B virus infection in Chinese Han population. Zhonghua Yi Xue Yi ChuanXueZaZhi23, : 4-410.
Garcia-Elorriaga G,Vera-Ramirez L,Rey-Pineda G del,Gonzalez-Bonilla C .2013 .-592 and -1082 interleukin-10 polymorphisms in pulmonary tuberculosis with type 2 diabetes. Asian Pac J Trop Med, 6 : 9-505.
Kolla VK,Madhavi G,Reddy B Pulla,Ramesh J,Akka J .2009 .Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes. Cytokine, 47 : 7-173.
Li J,S Wu J .2013 .-1082G/A and -819T/C gene polymorphisms with type 2 diabetes: a meta-analysis. Gene, 521(2) : 211-6.
Yin YW,Q Wang YW,C/ YW .2012 .A polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis of 5320 subjects. Hum Immunol, 73 : 5-960.
Kopelman PG .2000 .Obesity as a medical problem. Nature, 404(6778) : 635-43.
Scarpelli D,M Cardellini F,Andreozzi E,Laratta E .2006 .Variants of the interleukin-10promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasianitalian subjects. Diabetes, 55(5) : 1529-33.
Bluher M,M Fasshauer A,Tonjes J,Kratzsch J .2005 .Association of interleukin-6, C-reactive protein, interleukin-10and adiponectin plasma concentrations with measure s of obesity, insulin sensitivity and glucose metabolism. ExpClinEndocrinol Diabetes, 113(9) : 534-7.
Al-Shukaili A,Al-Ghafri S,Al-Marhoobi S,Al-Abri S,Al-Lawati J,Al-Maskari M .2013 .Analysis of inflammatory mediators in type 2 diabetes patients. Int J Endocrinol, : 9768-10.
Feng RN,C Zhao RN,Sun CH,Li Y .2011 .Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus. PLoS One, 6(4) : 18480.
Zhao Y,Li Z,Zhang L,Yang Y,Tang Y .2014 .The TNF-alpha-308G/A polymorphism is associated with type 2 diabetes mellitus: an updated meta-analysis. MolBiol Rep, 41(1) : 73-83.
Bai H,Jing D,Yin S .2014 .Association between interleukin 10 gene polymorphisms and risk of type 2 diabetes mellitus in a Chinese population. J Int Med Res, 42(3) : 702-10.
Crawley E,Sillibourne J,Patel P,Hutchinson I,Woo P .1999 .Polymorphic haplotypes of the interleukin‐105′ flanking region determine variable interleukin‐10transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis and Rheumatism: Official Journal of the American College of Rheumatology, 42(6) : 1101-1108.
Pennline KJ,Roque-Gaffney and M Monahan E .1994 .Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse Clinical Immunology and Immunopathology. , 71 : 169-175.
0

Citations

0

Downloads

136

Views